On this page

Adena Healthcare Collaborative, LLC

 

ACO Name and Location

Adena Healthcare Collaborative, LLC
272 Hospital Road
Chillicothe, OH 45601

ACO Primary Contact

Joseph Zakrzewski
740-773-7398 
jzakrzewski@adena.org

Organizational Information


ACO participants:

Adena Medical Group, LLC  N

ACO governing body:

Member

Title/position

Member’s Voting Power

Membership Type

ACO Participant Legal Business Name/DBA if applicable

Jim McManus

Chairperson

20%

ACO Participant Representative

Adena Health System

Devin Zakrzewski


20%

ACO Participant Representative

Adena Health System

Katherine Edrington


20%

ACO Participant Representative

Adena Health System

Robert Violette, MD

 

20%

ACO Participant Representative

Adena Medical Group, LLC

William Beatty

 

20%

Medicare Beneficiary 

 

     

 


   


Key ACO clinical and administrative leadership:

Joseph Zakrzewski  - ACO Executive
Robert Violette, MD - Medical Director
Kristin Boggs - Compliance Officer
Jessica Parsons - Quality Assurance/Improvement Officer

Associated committees and committee leadership:

Committee Name

Committee Leader Name and Position

Finance and Clinical Quality Committee

Dr. Robert Violette, Chair

Data and Analytics Committee 

Jessica Parsons and Rachel Collier, Co-Chairs


Types of ACO participants, or combinations of participants, that formed the ACO:

  • Critical Access Hospital (CAH) billing under Method II
  • Hospital employing ACO professionals
  • Partnerships or joint venture arrangements between hospitals and ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses 

Second Agreement Period

  • Performance Year 2021, $0
  • Performance Year 2020, $0
  • Performance Year 2019, $0
  • Performance Year 2018, $0

First Agreement Period

  • Performance Year 2017, $0
  • Performance Year 2016, $4,453,320
  • Performance Year 2015, $2,551,721

Shared Savings Distribution

Second Agreement Period

  • Performance Year 2021
  • Proportion invested in infrastructure: N/A
  • Proportion invested in redesigned care processes/resources: N/A
  • Proportion of distribution to ACO participants: N/A
  • Performance Year 2020
  • Proportion invested in infrastructure: N/A
  • Proportion invested in redesigned care processes/resources: N/A
  • Proportion of distribution to ACO participants: N/A
  • Performance Year 2019
  • Proportion invested in infrastructure: N/A
  • Proportion invested in redesigned care processes/resources: N/A
  • Proportion of distribution to ACO participants: N/A
  • Performance Year 2018
  • Proportion invested in infrastructure: N/A
  • Proportion invested in redesigned care processes/resources: N/A
  • Proportion of distribution to ACO participants: N/A

First Agreement Period

  • Performance Year 2017
  • Proportion invested in infrastructure: N/A
  • Proportion invested in redesigned care processes/resources: N/A
  • Proportion of distribution to ACO participants: N/A
  • Performance Year 2016
  • Proportion invested in infrastructure: 28%
  • Proportion invested in redesigned care processes/resources: 8%
  • Proportion of distribution to ACO participants: 64%
  • Performance Year 2015
  • Proportion invested in infrastructure: 25%
  • Proportion invested in redesigned care processes/resources: n/a
  • Proportion of distribution to ACO participants: 75%

Quality Performance Results

2021 Quality Performance Results:

Measure # Measure Name Rate ACO Mean
CAHPS-1 Getting Timely Care, Appointments, and Information 89.19 84.67
CAHPS-2 How Well Providers Communicate 95.74 93.56
CAHPS-3 Patient’s Rating of Provider 94.65 92.19
CAHPS-4 Access to Specialists 82.20 78.80
CAHPS-5 Health Promotion and Education 56.94 61.61
CAHPS-6 Shared Decision Making 57.20 60.89
CAHPS-7 Health Status and Functional Status 69.60 71.78
CAHPS-8 Care Coordination 89.08 85.66
CAHPS-9 Courteous and Helpful Office Staff 94.33 91.88
CAHPS-11 Stewardship of Patient Resources 23.51 24.71
001 Diabetes: Hemoglobin A1c (HbA1c) Poor Control 13.28 12.46
134 Preventative Care and Screening: Screening for Depression and Follow-up Plan 39.50 74.38
236 Controlling High Blood Pressure 69.05 74.87
318 Falls: Screening for Future Fall Risk 96.41 87.03
110 Preventative Care and Screening: Influenza Immunization 79.25 80.52
226 Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention 100.00 80.97
113 Colorectal Cancer Screening 66.56 73.63
112 Breast Cancer Screening 60.00 75.11
438 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 80.90 84.24
370 Depression Remission at Twelve Months 0.00 15.50
479 Hospital-Wide, 30-Day, All-Cause Unplanned Readmissions (HWR) Rate for MIPS Groups 0.1595 0.1540
MCC1 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions for ACOs (MCC) 35.69 33.99

Please note, the Quality ID #: 370 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size.

For previous years’ Financial and Quality Performance Results, please visit: data.cms.gov.